<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00477789</url>
  </required_header>
  <id_info>
    <org_study_id>802</org_study_id>
    <nct_id>NCT00477789</nct_id>
  </id_info>
  <brief_title>Effects of Allopurinol on Diastolic Function in Chronic Heart Failure Patients</brief_title>
  <official_title>Effects of Allopurinol on Diastolic Function in Chronic Heart Failure Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universita di Verona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universita di Verona</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In patients with chronic heart failure (CHF)due to dilated cardiomyopathy diastolic
      dysfunction occurs frequently and is related to a poor outcome. We have previously shown that
      parameters of diastolic function significantly correlate with uric acid levels, a marker of
      impaired oxidative metabolism. We aimed to determine whether inhibition of xanthine oxidase
      with allopurinol might affect diastolic function in patients with CHF.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>diastolic function uric acid levels BNP</measure>
    <time_frame>three months</time_frame>
  </primary_outcome>
  <condition>Chronic Heart Failure</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>allopurinol</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  chronic heart failure;

          -  left ventricular systolic dysfunction (ejection fraction &lt;45%)

          -  stable clinical conditions in the previous three months

          -  optimal medical therapy for CHF

          -  normal sinus rhythm

          -  written informed consent

          -  age &gt;18 years

        Exclusion Criteria:

          -  renal failure (s-creatinine &gt;2.5 mg/dl)

          -  already on allopurinol

          -  malignancies

          -  chronic inflammatory diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mariantonietta Cicoira, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Cardiology, University of Verona, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Division of Cardiology, University Hospital of Verona</name>
      <address>
        <city>Verona</city>
        <zip>37129</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 23, 2007</study_first_submitted>
  <study_first_submitted_qc>May 23, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 24, 2007</study_first_posted>
  <last_update_submitted>May 23, 2007</last_update_submitted>
  <last_update_submitted_qc>May 23, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 24, 2007</last_update_posted>
  <keyword>chronic heart failure</keyword>
  <keyword>diastolic dysfunction</keyword>
  <keyword>uric acid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Allopurinol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

